Definitive Contract 75D30120C09617
Award Date 8/31/20
Potential Completion Date 8/30/22
Potential Value $496K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the University of Alabama at Birmingham (UAB) for research and development facilities. The contract has a ceiling value of $51,806,163.19 and a completion date of December 31, 2008. UAB, a public research university and academic medical center, has extensive experience in federal contracting and grants, particularly in areas such as cancer...
- This is a definitive contract awarded by the U.S. government to the University of Alabama at Birmingham (UAB), a non-profit educational institution, on December 15, 2002. The contract has a firm fixed price of $1,497,441.00 and a completion date of June 30, 2007. There is no set-aside designation for this contract. UAB has an extensive track record of delivering biomedical and public health research under federal grant awards from agencies like the National Institutes of Health (NIH), Centers...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to the University of Alabama at Birmingham (UAB) for LAB DATA services. The $89,490 contract has an ultimate completion date of August 31, 2016. UAB, a public research university and academic medical center, has extensive experience securing federal contracts and grants, including work for the Department of Defense, NASA, and the Consumer Product Safety Commission. While this award does not...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB), doing business as U A B, for a "COMPREHENSIVE PANEL FOR VIRUSES" contract with a ceiling value of $1,053,577.42. The contract is under the broader In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery Contract (IDC) and has a completion date of September 29, 2016. UAB is a non-profit, public research university...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $499,760.00 firm fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for in vitro assessments of antimicrobial activity. This contract is under the parent "In Vitro Assessments of Antimicrobial Activity (IVAAA)" Indefinite Delivery Contract (IDC). UAB, a non-profit, state-controlled institution of higher...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) on August 22, 2017. The contract has a potential value of $845,508.52 and a completion date of September 15, 2018. The contract is for in vitro assessment for antimicrobial activity and a comprehensive viral screening panel. This delivery order is...
- The University of Alabama at Birmingham (UAB) was awarded a $42,411,498.54 Definitive Contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Extramural Activities (DEA) for biomedical research and services. This is a Cost No Fee contract with an ultimate completion date of December 1, 2013. UAB has a strong track record of securing federal funding for biomedical research, including grants from the National Institutes of Health (NIH). The contract does not...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $978,590.76 Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB) on August 15, 2014 for a "Comprehensive Panel for Viruses" requirement. This Delivery Order was placed under NIAID's In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery, Indefinite Quantity (IDIQ) contract and had a completion date of September 29, 2015. UAB, a public research university and academic...
- This is a $12,630,053.66 definitive, cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human Services to the University of Alabama at Birmingham (UAB) on September 30, 2004. The contract, which has no set-aside designation, is for the "Population Genetics Analysis Program: Immunity to Vaccines/Infections" and has a period of performance through July 31, 2010. As a leading research institution, UAB has a...
- This is a federal contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services (HHS), to the University of Alabama at Birmingham (UAB). The award is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery Contract, with a ceiling value of $847,402.67. The contract is for biomedical research and development, with no set-aside designation. UAB, a non-profit educational...